Cost-Effective Analysis (CEA) in the CTN: Bup/Nal Treatment for Opioid Addicted Youth Lead investigator information unavailable.

This ancillary study is related to CTN-0010, "Buprenorphine/Naloxone-Facilitated Rehabilitation for Heroin Addicted Adolescents/Young Adults."

The goals of this project are to (1) perform a comprehensive economic analysis of buprenorphine/naloxone-facilitated rehabilitation for opioid dependent adolescents/young adults by analyzing medical costs of treatment, cost-effectiveness, and cost-benefits (estimate the cost-effectiveness of the clinical intervention relative to the standard treatment in terms of cost per opioid free urine and in terms of cost per quality-adjusted life years (QALY) and estimate net social benefits, including reduced crime, improved education and job outcomes, and improved HIV risk behavior); and (2) illustrate the methods for economic analysis of substance abuse interventions in a clinical trial and facilitate replication of these methods by other investigators in the CTN network.

LATEST PUBLICATIONS AND DATA

	Find publications in the Library about Protocol CTN-0010a